Cobimetinib

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 473 publications

Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells.

Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells.

Journal: Journal of proteome research
Published: February 25, 2026

Azetidines in medicinal chemistry: emerging applications and approved drugs.

Azetidines in medicinal chemistry: emerging applications and approved drugs.

Journal: Future medicinal chemistry
Published: January 05, 2026

CHOROIDAL INFILTRATION IN ERDHEIM-CHESTER DISEASE: A CASE SERIES.

CHOROIDAL INFILTRATION IN ERDHEIM-CHESTER DISEASE: A CASE SERIES.

Journal: Retinal cases & brief reports
Published: December 22, 2025

Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

Developments of MEK inhibitors as future cancer therapies: what have we learned from preclinical and clinical studies?

Journal: Expert opinion on investigational drugs
Published: December 05, 2025

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy.

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma.

Targeting the MEK/ERK Pathway to Suppress P-Glycoprotein and Reverse Carfilzomib Resistance in Multiple Myeloma.

Journal: International journal of molecular sciences
Published: October 30, 2025

Accuracy of Budget Impact Projections in Bulgarian Health Technology Assessment: A Five-Year Validation Study (2020-2025).

Accuracy of Budget Impact Projections in Bulgarian Health Technology Assessment: A Five-Year Validation Study (2020-2025).

Journal: Healthcare (Basel, Switzerland)
Published: October 28, 2025

Erdheim-Chester Disease Masquerading as Leukemia: Outwitting the Need for Transplant.

Erdheim-Chester Disease Masquerading as Leukemia: Outwitting the Need for Transplant.

Journal: Cureus
Published: October 15, 2025

The use of MEK inhibitors in pediatric patients presenting with respiratory distress and laryngeal Rosai-Dorfman Disease: Two case reports.

The use of MEK inhibitors in pediatric patients presenting with respiratory distress and laryngeal Rosai-Dorfman Disease: Two case reports.

Journal: International journal of pediatric otorhinolaryngology
Published: October 13, 2025

Phase I study of ABM-1310 as monotherapy and in combination with cobimetinib for BRAF-mutated advanced solid tumors: safety, efficacy, and dose expansion.

Phase I study of ABM-1310 as monotherapy and in combination with cobimetinib for BRAF-mutated advanced solid tumors: safety, efficacy, and dose expansion.

Journal: ESMO open
Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances
Published: October 03, 2025

Mixed Erdheim-Chester disease with thoraco-abdominal involvement.

Mixed Erdheim-Chester disease with thoraco-abdominal involvement.

Journal: Acta radiologica open
Published: September 15, 2025
Showing 1-12 of 473

Last Updated: 04/28/2026